Overview
Hongbin Zhou practices practicing medicine in Hangzhou, China.
Their clinical expertise encompasses Chronic Obstructive Pulmonary Disease (COPD), Lung Cancer, Pneumonia, and Small Cell Lung Cancer (SCLC).
They are actively involved in clinical research, co-authoring 22 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hongbin Zhou
Is Hongbin Zhou a top-rated expert for Chronic Obstructive Pulmonary Disease (COPD)?
MediFind is an objective health platform that identifies experts based on real-world data. Hongbin Zhou is classified as an Experienced expert for Chronic Obstructive Pulmonary Disease (COPD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hongbin Zhou participate in research or clinical trials?
Yes. Hongbin Zhou has published 22 articles and abstracts on conditions like Chronic Obstructive Pulmonary Disease (COPD). You can view a list of Hongbin Zhou's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Chronic Obstructive Pulmonary Disease (COPD)
- Lung CancerZhou isExperienced. Learn about Lung Cancer.
- PneumoniaZhou isExperienced. Learn about Pneumonia.
- Small Cell Lung Cancer (SCLC)